programas cribado cancer

Nota bibliográfica cribado c próstata 2014-11

Kitagawa Y, Sawada K, Urata S, Izumi K, Ueno S, Kadono Y, et al. Impact of PSA Levels on Second-round Screening for the Development of Prostate Cancer in Men with Low Baseline PSA Levels (Anticancer Res. Greece; 2014;34(11):6739–46. PMID: 25368284.

CONCLUSION: The present study demonstrated that serum PSA levels at second round screening were a strong predictor of cancer development in men with baseline PSA levels ng/ml at the first population screening.

Prasad V. It is time to stop screening for prostate cancer. JAMA Intern Med. United States; 2014;174(11):1841–2. doi: 10.1001/jamainternmed.2014.3078.
PMID: 25178980.

Louie KS, Seigneurin A, Cathcart P, Sasieni P. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis. Ann Oncol. 2014; Available from: doi: 10.1093/annonc/mdu525.

Conclusions Risk prediction models improve the predictive accuracy of PSA testing to detect PCa. Future developments in the use of PCa risk models should evaluate its clinical effectiveness in practice

web desarrollada y mantenida por :